Earnings took center stage again with a disappointment from IBM (IBM) and a better-than-expected performance from Morgan Stanley (MS) dividing markets. The Dow fell for its second day in a row. Morgan Stanley gave rise to the financials sector after posting increases in its quarterly earnings and revenue. The New York-based firm joined Citigroup (C) , JPMorgan (JPM) and Bank of America (BAC) in reporting a solid first quarter. Crude oil prices held near the flatline after a weekly reading on inventories showed a decline, though not as steep as analysts anticipated. U.S. stockpiles shrank by 1 million barrels, more than half the drop a week earlier. Abbott Laboratories (ABT) was active after beating estimates on its top- and bottom-line. Sales grew nearly 30% in a year full of acquisitions and product launches.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.